A federal advisory committee will vote on whether regulators should authorize a COVID-19 vaccine made by Novavax. From The New York Times.
A federal advisory committee Tuesday will vote on whether regulators should authorize a COVID-19 vaccine made by Novavax, an early beneficiary of the government’s Operation Warp Speed program.
In clinical trials, the Novavax vaccine was found to have an efficacy of 90.4% at preventing mild, moderate or severe infection with older variants of the virus. None of the volunteers who got the vaccine experienced moderate or severe infection, translating to an efficacy of 100%. “These events raise the concern for a causal association with this vaccine,” the FDA documents stated.
The Novavax vaccine has been authorized in dozens of countries, including India, South Africa and Britain, and has also received clearance from the European Union and World Health Organization.But the vaccine is falling far short of initial hopes, both in terms of the number of vaccines distributed around the world and the number of people who are receiving them. In February 2021, Novavax pledged 1.1 billion doses to COVAX, the U.N. program supplying shots to developing countries.
As part of its initial support for Novavax’s research, the United States agreed to buy 110 million doses of the vaccine if it won authorization. But two years later, with the country already flush with effective mRNA vaccines, the government has little need for more.
日本 最新ニュース, 日本 見出し
Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。
Novavax Covid-19 Vaccine Faces FDA Advisers’ ScrutinyThe outside panel of experts will vote on whether the shot should be authorized, after the agency found it effective but flagged a safety concern.
続きを読む »
Novavax hoping its COVID-19 vaccine using traditional technology wins over vaccine skepticsThe Novavax COVID-19 vaccine is made with an old school technology, but will it be enough to win over vaccine skeptics?
続きを読む »
Latest U.S. Covid-19 Surge Moves West as Pressure Eases in NortheastThirteen California counties now have high Covid-19 community levels as the latest U.S. wave shifts westward. There are also signs of easing pressure in the Northeast.
続きを読む »
Trained dogs sniff out COVID-19 as well as lab tests doAnd the canines are even better than PCR tests at identifying infected people with no symptoms. COVID19 pcrtest dogs COVIDTesting pandemic Science
続きを読む »
Trained dogs sniff out COVID-19 as well as lab tests doDogs can be trained to sniff out COVID-19 cases. They’re overall as reliable as PCR tests and even better at IDing asymptomatic cases, a study suggests.
続きを読む »
Orange County man to plead guilty to $5-million COVID-19 relief loan scamRaghavender Reddy Budamala reportedly used the loans to purchase a $1.2 million 'investment property' in Eagle Rock, a nearly $600,000 property in Malibu and a 'personal residence' in Irvine.
続きを読む »